Federal Register / Vol. 66, No. 101 / Thursday, May 24, 2001 / Notices 28757

Place: 7201 Wisconsin, Suite 502C,

Bethesda, MD 20892.

Contact Person: Mary Ann Guadagno,

Scientific Review Administrator, The

Bethesda Gateway Building, 7201 Wisconsin

Avenue, Suite 2C212, Bethesda, MD 20892,

(301) 496–9666.

Name of Committee: National Institute on

Aging Special Emphasis Panel.

Date: June 22, 2001.

Time: 1 a.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: 7201 Wisconsin, Suite 502C,

Bethesda, MD 20892. (Telephone Conference

Call).

Contact Person: William A. Kachadorian,

The Bethesda Gateway Building, 7201

Wisconsin Avenue, Suite 2C212, Bethesda,

MD 20892, (301) 496–9666.

Name of Committee: National Institute on

Aging Special Emphasis Panel, Novel

Mechanisms of NSAID Action in Alzheimer’s

Disease.

Date: June 25–26, 2001.

Time: 6 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Mariott La Jolla, 4240 La Jolla

Village Drive, La Jolla, CA 92037.

Contact Person: Ramesh Vemuri, Health

Scientific Administrator, Office of Scientific

Review, National Institute on Aging, The

Bethesda Gateway Building, 7201 Wisconsin

Avenue, Suite 2C212, Bethesda, MD 20892,

(301) 496–9666.

Name of Committee: National Institute on

Aging Special Emphasis Panel.

Date: June 26, 2001.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 7201 Wisconsin Avenue, Bethesda,

MD 20892 (Telephone Conference Call).

Contact Person: Arthur D. Schaerdel, The

Bethesda Gateway Building, 7201 Wisconsin

Avenue, Suite 2C212, Bethesda, MD 20892,

(301) 496–9666.

Name of Committee: National Institute on

Aging Special Emphasis Panel.

Date: June 27–29, 2001.

Time: 6 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday, Inn, 5520

Wisconsin Ave., Chevy Chase, MD 20815.

Contact Person: Jerry M. Chernak, The

Bethesda Gateway Building, 7201 Wisconsin

Avenue, Suite 2C212, Bethesda, MD 20892,

(301) 496–9666.

Name of Committee: National Institute on

Aging Special Emphasis Panel.

Date: June 9–10, 2001.

Time: 7:30 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 4100 Presidential

Blvd., Philadelphia, PA 19131.

Contact Person: James P. Harwood, Deputy

Chief, Scientific Review Office, The Bethesda

Gateway Building, 7201 Wisconsin Avenue,

Suite 2C212, Bethesda, MD 20892, (301) 496–

9666.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.866, Aging Research,

National Institutes of Health, HHS)

Dated: May 17, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13112 Filed 5–23–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Office of the Director; Notice of

Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Recombinant DNA Advisory Committee.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: June 14–15, 2001.

Date: June 15–14, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: The committee will review

selected human gene transfer protocols; NIH

policy on serious adverse event reporting;

data management activities related to human

gene transfer clinical trials; discussion on the

risk group designation for E. coli strain B;

and other matters to be considered by the

Committee.

Place: Natcher Building, Conference Room

D, 45 Center Drive, Bethesda, MD 20892.

Contact Person: Amy P. Patterson, MD,

Acting Executive Secretary, Office of

Biotechnology Activities, National Institutes

of Health, 6705 Rockledge Drive, Suite 750,

Bethesda, MD 20892, 301–496–9838.

Information is also available on the

Institute’s/Center’s home page:

www4.od.nih.gov/oba/, where an agenda and

any additional information for the meeting

will be posted when available.

Note: ‘‘Mandatory Information

Requirements for Federal Assistance Program

Announcements’’ (45 FR 39592, June 11,

1980) requires a statement concerning the

official government programs contained in

the Catalog of Federal Domestic Assistance.

Normally NIH lists in its announcements the

number and title of affected individual

programs for the guidance of the public.

Because the guidance in this notice covers

virtually ever NIH and Federal research

program in which DNA recombinant

molecule techniques could be used, it has

been determined not to be cost effective or

in the public interest to attempt to list these

programs. Such a list would likely require

several additional pages. In addition, NIH

could not be certain that every Federal

program would be included as many Federal

agencies, as well as private organizations,

both national and international, have elected

to follow the NIH Guidelines. In lieu of the

individual program listing, NIH invites

readers to direct questions to the information

address above about whether individual

programs listed in the Catalog of Federal

Domestic Assistance are affected.

Dated: May 17, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13109 Filed 5–23–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Changes to a Fiscal Year (FY) 2001

Funding Opportunities Notice

AGENCY: Center for Substance Abuse

Prevention (CSAP), Substance Abuse

and Mental Health Services

Administration (SAMHSA), DHHS.

ACTION: Modification/Clarification of a

Notice of Funding Availability

Regarding the Substance Abuse and

Mental Health Services Administration,

Center for Substance Abuse Prevention

Minority HIV Prevention Initiatives

Funding Announcement.

SUMMARY: This notice is to inform the

public that the SAMHSA/CSAP

announcement No. SP–01–006, Targeted

Capacity Expansion Initiatives for

Substance Abuse Prevention (SAP) and

HIV Prevention (HIVP) in Minority

Communities (Short Title: Minority HIV

Prevention Initiatives) will be changed.

Effective immediately, ALL domestic

public and private non-profit, youthserving, community-based organizations

that serve predominantly racial and

ethnic minority populations

disproportionately impacted by the

HIV/AIDS epidemic will be eligible to

apply for Category 3 funds; eligibility

will not be restricted to faith-based

organizations or to community-based

organizations collaborating with faithbased organizations.

This change in eligibility will ensure

that all community-based, youth-serving

organizations will have an opportunity

to compete for funding on an equal

footing. The emphasis is on an

organization’s qualifications and

capacity to effectively provide substance

abuse prevention and HIV prevention

services to racial and ethnic minority

youth, not on its secular or religious

status. Faith-based organizations

continue to be eligible to apply for

funding in all three categories and will,

like all other applicants, be evaluated

based on how well they can provide the